Silverback Therapeutics’ Merger With ARS Pharmaceuticals

Cooley represented Silverback, Kirkland & Ellis advised Nextech, Inceptiv Law advised ARS on the deal.Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) and ARS Pharmaceuticals, Inc. (“ARS”) have…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now